Mankind Pharma launches “Azilsartan” an Anti-Hypertensive drug at most affordable price Rs 7.50
Bengaluru, 16th May, 2017: Mankind Pharma, a quality driven pharmaceutical company in India launches Anti-Hypertensive-drug Zolahart (Azilsartan), at an affordable price of Rs 7.50 per tablet. Aiming at reducing the most commonly related disease of Hypertension, the introduction of Zolahart (Azilsartan) at 51% less price, is done with the mission of achieving the prime objective of – world class quality at most affordable price.
Research bythe World Health Organization (WHO), shows that hypertension is one of theleading causes of premature deaths in India. It also exerts substantial publichealth burden on the cardiovascular health status of India.
Azilsartan,a new generation Anti-hypertensive drug, offers potent and persistent 24 hours’blood pressure control. It is proven to be safe for hypertensive patients withcomorbid conditions like Diabetes or Chronic Kidney Disease (CKD). The recentlylaunched Angiotensin-receptor-blocker (Azilsartan) is the most potent amongstARBs and is expected to reduce the proportion of patients of uncontrolled BP considerably.
Speaking onthe development, Mr. R.C. Juneja, chairman and founder, Mankind Group said “AtMankind, we endeavour to bring the latest innovative therapies with assuredquality that address primary healthcare challenge in India – world class qualityat an affordable price. It is with this thought, we decided to launch Zolahart(Azilsartan), the latest Anti-Hypertensive Drug at the most affordable price of7.50/Tab” which is 51% less than other competitors.
Inspired byPradhan Mantri Jan Aushadi Scheme to deliver pharmaceuticals products ataffordable price, Mankind Pharma with its Make in India approach has set upgoals to sustain a balance in the healthcare of the country.